|
Diseases | lncRNA | Full name | Expression level | Assessed cell line | Signaling pathways and molecules | Functions | In other diseases | References |
|
Nonobstructive azoospermia (NOA) | NLC1-C | Narcolepsy candidate-region 1 gene | Downregulated | NCCIT, NTERA-2 (NT2), HEK293 T | Sponge for miR-320a, miR-383 | Inhibits miR-320a and miR-383 transcripts by binding to nucleolin, resulting in a hyperactive proliferation of germ cells | Testicular embryonal carcinoma | [71] |
GM2044 | — | Upregulated | NCCIT | miR-202-Rbfox2 pathway | Inhibits the proliferation of the human testicular embryonic carcinoma cell NCCIT | — | [79] |
HOTAIR | Hox transcript antisense intergenic RNA | Downregulated | — | NRF2 | Relates to defects in sperm function | Breast cancer, lung cancer, and pancreatic cancer | [80, 81, 123] |
Gadd7 | lncRNA growth-arrested DNA damage-inducible gene 7 | Upregulated | GC-1, GC-2 | Bax, Bcl2 | Inhibits cell growth and promotes apoptosis by upregulating the proapoptotic regulator Bax and downregulating the antiapoptotic regulator Bcl2 | — | [82] |
Prostate tumors | PRNCR1/PCGEM1 | Prostate cancer-associated noncoding RNA 1/PCGEM1 prostate-specific transcript | Upregulated | LNCaP, LNCaP-cds1, LNCaP-cds2, CWR22Rv1 | AR | Promotes the proliferation of prostate cancer cells | Breast cancer and lung cancer | [84, 124] |
NEAT1 | Nuclear-rich transcriptase 1 | Upregulated | LNCaP and PC3, RWPE1, VCaP and DU145 | Estrogen receptor alpha (ERα) | Promotes the development of prostate cancer | Non-small-cell lung cancer, breast cancer, and hepatocellular carcinoma | [85, 125] |
PCAT-1 | Prostate cancer-associated transcript-1 | Upregulated | LNCaP | PRC2, cMyc | Promotes the proliferation of prostate cancer cells | Colorectal cancer, hepatocellular cancer, and gastric cancer | [86, 126] |
MALAT-1 | Metastasis-associated lung adenocarcinoma transcript 1 | Upregulated | LNCaP-AI, 22RV1 | ZEB1, ZEB2, Slug | Is associated with the increase in the Gleason score, prostate-specific antigen (PSA), and tumor stage and promotes the invasion and growth of prostate cancer cells | Glioma, hepatocellular carcinoma, and multiple myeloma | [87, 127] |
SChLAP1 | Second chromosome locus associated with prostate-1 | Upregulated | — | — | Relates to poor prognosis and could be used as an important biomarker to identify patients with a high risk of lethal prostate cancer | Triple negative breast cancer and bladder cancer | [88, 128, 129] |
GAS5 | Growth arrest specific 5 | Downregulated | PC3, DU145, and PNT2C2 | E2F1, P27Kip1 | Induces a cell cycle arrest in the G0–G1 phase and acts as a tumor suppressor | Colorectal cancer, gastric cancer, and melanoma | [89] [89, 130] |
Ovarian cancer | XIST | Inactive X chromosome-specific transcripts | Downregulated | ALST, CAOV3, OVCA3, OVCA420, OVCA429, OVCA432, OVCA433, OVCA633, OVCA680, OVCA702, OVCA810, SKOV3, ES-2, TOV21G | XIAP | Downregulation of Xist may increase the expression of linked inhibitors of apoptosis protein and lead to the phenotype of drug | Non-small-cell lung cancer, breast cancer, and primary hepatocellular carcinoma | [91, 131, 132] |
H19 | Imprinted maternally expressed transcript | Upregulated | SKOV3, OV90, TOV112D, ES2 | Caspase-3, caspase-9, Bax, Bcl-2, cyclin B1/Cdc2 | Promotes ovarian cancer cell proliferation | Head and neck cancer, pancreatic cancer, and osteosarcoma | [92, 93, 133] |
MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 | Upregulated | SKOV3, SKOV3.ip1, 293T | — | Promotes cell proliferation and metastasis and inhibits cell apoptosis | Glioma, hepatocellular carcinoma, and multiple myeloma | [94–96, 127] |
LINC00565 | Long intergenic nonprotein coding RNA 565 | Upregulated | OVCAR3, SKOV3, HO8910, A2780, and HEY | GAS6, cyclinE1, cyclinD1, CDK4 P16, P21 | Relates to the FIGO (International Federation of Gynecology and Obstetrics) stage, cell cycle, and size of tumor cells and promotes cell proliferation, invasion, and migration | Gastric cancer and colorectal cancer | [97, 134, 135] |
DARS-AS1 | DARS1 antisense RNA 1 | Upregulated | A2780, SKOV3, and OVCAR-3 | Sponge for miR-532-3p | Promotes the proliferation, migration, and invasion of ovarian cancer cells | Thyroid cancer, clear cell renal cell carcinoma, and non-small-cell lung cancer | [98, 136, 137] |
FEZF1-AS1 | FEZF1 antisense RNA 1 | Upregulated | SKOV-3, HO8910, HO8910PM, ES2, and HG-SOC | JAK-STAT3 pathway | Relates to poor prognosis, promotes cell proliferation, and inhibits cell apoptosis | Colorectal cancer, gastric neoplasia, and hepatocellular carcinoma | [99, 138] |
LEF1-AS1 | LEF1 antisense RNA 1 | Upregulated | SKOV3, OVCAR3 | miR-1285-3p | The absence of LEF1-AS1 results in inhibiting proliferation, migration, and invasion of ovarian cancer cells | Glioblastoma, colorectal cancer, and retinoblastoma | [100, 139–141] |
Endometrial carcinoma (EC) | H19 | Imprinted maternally expressed transcript | Upregulated | — | — | Regulates migration and invasion of the tumor cells | Head and neck cancer, pancreatic cancer, and osteosarcoma | [102, 133] |
CCAT1 | Colon cancer-associated transcript 1 | Upregulated | HEC-1-A, KLE, Ishikawa | Sponge for miR-181a-5p | Promotes the proliferation and migration of endometrial cancer cells | Breast cancer and multiple myeloma | [103, 142] |
MIR22HG | MIR22 host gene | Downregulated | HEC-1 A, KLE | Sponge for miR-141-3p | Inhibits the proliferation and migration and promotes the apoptosis of cancer cells | Esophageal cancer, lung cancer, and hepatocellular carcinoma | [104, 143] |
MEG3 | Maternal expression gene 3 | Downregulated | Ishikawa, HEC-1B | PI3K/m-TOR pathway, BclxL, VEGFA | High expression of MEG3 inhibits the migration, invasion, and proliferation of EC cells and increases apoptosis | Gastric cancer, osteosarcoma, and breast cancer | [105, 144] |
Endometriosis | AC002454.1 | — | Upregulated | — | CDK6 | Promotes the migration, invasion, and proliferation of cells and regulates the cell cycle | Bladder cancer | [107, 145] |
MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 | Upregulated | — | NF-κB/iNOS pathway, MMP-9, caspase-3 | Promotes the proliferation and migration of endometrial cells | Glioma, hepatocellular carcinoma, and multiple myeloma | [108, 127] |
AFAP1-AS1 | Actin filament-associated protein 1 Antisense RNA1 | Upregulated | Ishikawa | ZEB1 | Promotes the EMT process of endometriosis | Esophageal cancer, pancreatic ductal adenocarcinoma | [109, 146] |
CCDC144NL-AS1 | CCDC144NL antisense RNA 1 | Upregulated | hEM15A | MMP-9, F-actin, vimentin | Affects the cytoskeleton structure and promotes cell invasion and migration | Osteosarcoma, gastric cancer, non-small-cell lung cancer, and hepatocellular carcinoma | [110, 147–150] |
TC0101441 | — | Upregulated | ECSCs | TCF8/ZEB1, slug, snail, and N-cadherin | EV shuttling of TC0101441 promotes invasion and migration of endometriosis | Gastric cancer | [151, 152] |
UCA1 | Urothelial carcinoma-associated-1 | Downregulated | — | — | Is involved in the pathogenesis of endometriosis and can be used as a biomarker for diagnosis and prognosis | Urothelial carcinoma-associated 1 gastric cancer and colorectal cancer | [153, 154] |
H19 | Imprinted maternally expressed transcript | Downregulated | 293T, HESCs | H19/Let-7/IGF1R, H19/miR-216a-5p/ACTA2 pathway | Regulates endometrial stromal cell proliferation, invasion, and migration | Head and neck cancer, pancreatic cancer, and osteosarcoma | [133, 155, 156] |
aHIF | Antisense hypoxia-inducible factor | Upregulated | ECSCs, HUVECs | (VEGF)-A, VEGF-D | Facilitates endometriosis angiogenesis and is used as a potential biomarker and therapeutic target for endometriosis | Gastric cancer, glioblastoma multiforme, and paraganglioma | [157–159] |
Cervical cancer | MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 | Upregulated | — | HeLa, CaSki | Promotes the proliferation and invasion of cervical cancer cells and reduces apoptosis | Glioma, hepatocellular carcinoma, and multiple myeloma | [112, 127] |
HOTAIR | Hox transcript antisense intergenic RNA | Upregulated | SiHa, HeLa, Caski | VEGF, MMP-9, E-cadherin, β-catenin, vimentin, snail, twist | Promotes metastasis and invasion of tumor cells | Breast cancer, lung cancer, and pancreatic cancer | [113, 123] |
RP11-480I12.5 | — | Upregulated | PCS-480-011, SiHa (HTB-35), HeLa229 (CCL-2.1), and MS751 | Wnt/β-catenin pathway | Induces EMT through the Wnt/β-catenin pathway and promotes migration, invasion, and proliferation of cervical cancer cell lines | Breast cancer | [114, 160, 161] |
RP1-93H18.6 | — | Upregulated | SiHa, HeLa, CaSki, and C-33A | PI3K/Akt/mTOR pathway | Promotes growth and metastasis of tumor cells and reduces apoptosis | — | [115] |
DSCAM-AS1 | DSCAM antisense RNA 1 | Upregulated | SiHa, HeLa, C-33A, and CaSki | Sponge for miR-361-5p | Enhances the ability of cells to migrate, invade, and proliferate and promotes the development of cervical cancer | Non-small-cell lung cancer, colorectal cancer, and osteosarcoma | [116, 162] |
GAS5-AS1 | GAS5 antisense RNA 1 | Downregulated | Caski, SiHa, C33A, and HeLa | GAS5 | Relates to the FLGO stage, lymphatic metastasis, distant metastasis, and poor prognosis and promotes proliferation, migration, and invasion | Glioma, non-small-cell lung cancer, and hepatocellular carcinoma | [117, 153, 163, 164] |
PVT1 | Plasmacytoma variant translocation-1 | Upregulated | HeLa and SiHa | Sponge for miR-140-5p, Smad3 | Promotes the proliferation and metastasis of cervical cancer | Clear cell renal cell carcinoma and thyroid cancer | [118, 165] |
Polycystic ovary syndrome (PCOS) | H19 | Imprinted maternally expressed transcript | Upregulated | Peripheral blood leukocytes | FPG | May be a key factor in endocrine and metabolic diseases in patients with PCOS | Head and neck cancer, pancreatic cancer, and osteosarcoma | [120, 133] |
PVT1 | Plasmacytoma variant translocation-1 | Upregulated | — | Sponge for miR-17-5p | Regulates the apoptosis and the proliferation of ovarian granulosa cells | Clear cell renal cell carcinoma and thyroid cancer | [165, 166] |
LET | Low expression in tumor | Downregulated | KGN | Wnt/β-catenin and Notch pathways, TIMP2 | Promotes cell migration and survival and inhibits cell apoptosis | Hepatocellular carcinoma, colorectal cancer, and squamous cell lung carcinoma tissues | [167, 168] |
TMPO-AS1 | TMPO antisense RNA 1 | Upregulated | COV434 | Sponge for miR-355-5p | Serve as a potential target to treat PCOS | Lung cancer, breast cancer, and colorectal cancer | [169, 170] |
NEAT1 | Nuclear-rich transcriptase 1 | Upregulated | Ovarian tissue in rats | Sponge for miR-381, IGF1 | Promotes cell proliferation and represses cell apoptosis | Non-small-cell lung cancer, breast cancer, and hepatocellular carcinoma | [125, 171] |
LINC00477 | Long intergenic nonprotein coding RNA 477 | Upregulated | Sponge for miR-128 | Sponge for miR-128 | LINC00477/miR-128 axis may represent a potential method for the treatment of PCOS | Gastric cancer | [172, 173] |
|